Intrinsiqs

Is CAMP4 Therapeutics Corporation overvalued?

CAMP4 Therapeutics Corporation (CAMP) — key valuation metrics and fundamentals.

No verdict
Price
$5.44
Fair value
Current P/E
Normal P/E
27.8
Market cap
$115.5M
Dividend yield
0.0%
Return on equity
-194.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CAMP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.